Abstract
The rationale for surfactant replacement therapy in patients with acute respiratory distress syndrome (ARDS) is to restore the normal composition of the surfactant system, as well as to overcome ongoing inactivation of present surfactant. Indeed, surfactant replacement therapy can normalize the composition of the surfactant system and restore its surface activity, which results in restoration of the gas exchange. Several phase II- and phase III-studies have been performed to investigate safety and efficacy of surfactant replacement therapy in patients with ARDS. In this manuscript we will discuss the differences in the composition of exogenous surfactant, the diverse modes of delivery of surfactant, and timing of therapy, in relation to the efficacy of surfactant instillation in several published and yet unpublished studies.
Keywords: Additive Drug, ARDS-Patients, exogenous surfactant
Current Drug Targets
Title: Is Surfactant a Promising Additive Drug in ALI / ARDS-Patients?
Volume: 5 Issue: 5
Author(s): Marcus J. Schultz and Jozef Kesecioglu
Affiliation:
Keywords: Additive Drug, ARDS-Patients, exogenous surfactant
Abstract: The rationale for surfactant replacement therapy in patients with acute respiratory distress syndrome (ARDS) is to restore the normal composition of the surfactant system, as well as to overcome ongoing inactivation of present surfactant. Indeed, surfactant replacement therapy can normalize the composition of the surfactant system and restore its surface activity, which results in restoration of the gas exchange. Several phase II- and phase III-studies have been performed to investigate safety and efficacy of surfactant replacement therapy in patients with ARDS. In this manuscript we will discuss the differences in the composition of exogenous surfactant, the diverse modes of delivery of surfactant, and timing of therapy, in relation to the efficacy of surfactant instillation in several published and yet unpublished studies.
Export Options
About this article
Cite this article as:
Schultz J. Marcus and Kesecioglu Jozef, Is Surfactant a Promising Additive Drug in ALI / ARDS-Patients?, Current Drug Targets 2004; 5 (5) . https://dx.doi.org/10.2174/1389450043345399
DOI https://dx.doi.org/10.2174/1389450043345399 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The CRF Receptor Structure, Function and Potential for Therapeutic Intervention.
Current Medicinal Chemistry - Central Nervous System Agents COVID-19 Pandemic: An Overview of its Origin, Current Status, and Ongoing Clinical Trials
Coronaviruses Alstrom Syndrome: Genetics and Clinical Overview
Current Genomics Meet Our Editor-in-Chief
Current Psychopharmacology Current Progresses of Novel Natural Products and Their Derivatives/ Analogs as Anti-Alzheimer Candidates: an Update
Mini-Reviews in Medicinal Chemistry Privileged Structures: Applications in Drug Discovery
Combinatorial Chemistry & High Throughput Screening Predict Drug-Protein Interaction in Cellular Networking
Current Topics in Medicinal Chemistry Recent Progress in the Development of HIV-1 Entry Inhibitors: From Small Molecules to Potent Anti-HIV Agents
Current Topics in Medicinal Chemistry In Silico Methods Applied in Food Chemistry: A Short Review with Bitter and Mutagenic Compounds
Letters in Drug Design & Discovery Current Research Trends in Cytokine Storm: A Scientometric Study
Current Drug Targets Attacking the SARS-CoV-2 Replication Machinery with the Pathogen Box’s Molecules
Letters in Drug Design & Discovery Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Recent Patents on CNS Drug Discovery (Discontinued) Carbazole Scaffold in Medicinal Chemistry and Natural Products: A Review from 2010-2015
Current Topics in Medicinal Chemistry Designing Peptide Mimetics for the Treatment of Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry Design, Synthesis and 3-D Characterization of 1-Benzenesulfonyl-1,2,3,4- Tetrahydroquinolines as Lead Scaffold for Antiparasitic Drug
Letters in Drug Design & Discovery Cyanosis Due to Methemoglobinemia Induced by Topical Anesthesia in a Premature Infant
Current Drug Therapy Carotenoids and Cardiovascular Risk
Current Pharmaceutical Design An Easy Assembled, Click-Generated Macrocyclic Chromoionophores as Mercury(II) Sensors
Letters in Organic Chemistry Pituitary Stem Cells Drop Their Mask
Current Stem Cell Research & Therapy Understanding the Structural Basis for Inhibition of Cyclin-Dependent Kinases. New Pieces in the Molecular Puzzle
Current Drug Targets